Open
由一群熱情的電腦科學(xué)家與資訊工程師與專業(yè)醫(yī)師們於2018年成立公司。技術(shù)專長涵蓋醫(yī)學(xué)、人工智慧、資料分析、擴增實境等領(lǐng)域。經(jīng)理人團隊有成功多家創(chuàng)業(yè)並上市櫃的經(jīng)驗。
專注於骨骼與心血管慢性病之AI軟體醫(yī)療器材開發(fā)，實現(xiàn)慢性病的早期發(fā)現(xiàn)、精準(zhǔn)診斷與有效追蹤，以期提供高齡長者即時、方便且可負擔(dān)的智慧醫(yī)療服務(wù)。其中X光影像自動分析解決方案DeepXray™已獲得FDA上市許可。
A company was founded in 2018 by a group of passionate computer scientists, information engineers, and medical professionals. Their technical expertise spans across fields such as medicine, artificial intelligence, data analysis, and augmented reality. The management team has experience in successfully founding and taking several companies public.
The company focuses on the development of AI software and medical devices for chronic diseases in the skeletal and cardiovascular systems, aiming to achieve early detection, precise diagnosis, and effective monitoring of chronic diseases. The goal is to provide elderly individuals with timely, convenient, and affordable smart healthcare services. One of their solutions, DeepXray™, an automatic analysis solution for X-ray images, has received FDA approval for market release.
專注於骨骼與心血管慢性病之AI軟體醫(yī)療器材開發(fā)，實現(xiàn)慢性病的早期發(fā)現(xiàn)、精準(zhǔn)診斷與有效追蹤，以期提供高齡長者即時、方便且可負擔(dān)的智慧醫(yī)療服務(wù)。其中X光影像自動分析解決方案DeepXray™已獲得FDA上市許可。
A company was founded in 2018 by a group of passionate computer scientists, information engineers, and medical professionals. Their technical expertise spans across fields such as medicine, artificial intelligence, data analysis, and augmented reality. The management team has experience in successfully founding and taking several companies public.
The company focuses on the development of AI software and medical devices for chronic diseases in the skeletal and cardiovascular systems, aiming to achieve early detection, precise diagnosis, and effective monitoring of chronic diseases. The goal is to provide elderly individuals with timely, convenient, and affordable smart healthcare services. One of their solutions, DeepXray™, an automatic analysis solution for X-ray images, has received FDA approval for market release.